Search & Filter

More than 600 children and teenagers are being treated for type 2 diabetes €“ a condition normally seen in those over 40, the Local Government Association has said.

Liver cancer drug sorafenib has been approved for routine NHS use, meaning NICE has now made it three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.

An extra 71,000 care home places will be needed in England in just eight years to cope with rising numbers of older people unable to live independently, new research has revealed.

The rate of people dying from bowel cancer in the UK has plummeted by more than 30% in the past 20 years, according to new figures released by Cancer Research UK.

Hundreds more people are surviving heart failure thanks to improvements in patient care, a new independent study has found.

Sepsis or pneumonia in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year, according to research published in the European Journal of Preventive Cardiology.

NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.

medi, one of the leading manufacturers of medical devices, is introducing new two-tone compression stockings that can be used for the treatment of oedema.

GM invites submissions dealing with the treatment in general practice of common ailments (such as heart disease, pain, or osteoporosis) in the 50+ patient.

England's Chief Nursing Officer has launched a 10 point action plan that aims to develop the roles that general practice nurses have, helping to transform care and futureproof nursing in general practice.

NICE has called for GPs to develop a national autism register, which would ensure autistic people receive the tailored care they need.

Periodontal disease has been associated with an increased risk of several types of cancer in postmenopausal women, a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention revealed.

The European Commission has approved an update to the liraglutide (Victoza) EU label that expands the indication to reflect both improving blood sugar and cardiovascular (CV) events as integral parts of type 2 diabetes treatment.

New research into the genetic and molecular features of cancers that have spread has revealed the diversity of these tumours and the immune cells within. 

Researchers at Penn Medicine have discovered that a patient's awareness of a diagnosis of cognitive impairment may diminish their self-assessment of quality of life.